Cargando…
Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan
BACKGROUND: The large consumption of neuraminidase inhibitors (NAIs) for the treatment of influenza virus infections places Japan at risk of becoming the epicenter of the global spread of NAI‐resistant viruses. OBJECTIVE: To clarify NA amino acid mutations of epidemic influenza viruses in Japan and...
Autores principales: | Chong, Yong, Matsumoto, Shinya, Kang, Dongchon, Ikematsu, Hideyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379637/ https://www.ncbi.nlm.nih.gov/pubmed/30548432 http://dx.doi.org/10.1111/irv.12624 |
Ejemplares similares
-
Long-acting Neuraminidase Inhibitor Laninamivir Octanoate as Post-exposure Prophylaxis for Influenza
por: Kashiwagi, Seizaburo, et al.
Publicado: (2016) -
Systematic review of influenza resistance to the neuraminidase inhibitors
por: Thorlund, Kristian, et al.
Publicado: (2011) -
Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011) -
Bacterial Neuraminidase Rescues Influenza Virus Replication from Inhibition by a Neuraminidase Inhibitor
por: Nishikawa, Tomoko, et al.
Publicado: (2012) -
Effectiveness of four types of neuraminidase inhibitors approved in Japan for the treatment of influenza
por: Mawatari, Momoko, et al.
Publicado: (2019)